Approval · Notice of Compliance 17716 · 2016
ERBITUX: Notice of Compliance 17716
Issued January 22, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17716
- Date
- January 22, 2016
- Company
- Imclone LlcBranchburg, New Jersey, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERBITUX | Not yet assigned | — |
Medicinal ingredients
- CETUXIMAB 2 MG per ML